Sfoglia per AUTORE
PERRONE V
Collezione ASL Vercelli

  

Items : 16

Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation) in Global and Regional Health Technology Assessment

2024
ASL VCO
ASL Vercelli

Perrone V; Medea G; Urbinati S; Sangiorgi D; Esposti LD; Andretta M; Bacca M; Barbieri A; Bartolini F; Caputo M; Cavaliere A; Ciaccia A; Costantini A; Ferrante F; Gentile S; Grego S; Lavalle A; Lupi A; Maccio S; Mancini D; Moscogiuri R; Procacci C; Re D; Santoleri F;

Profile, Healthcare Resource Consumption and Related Costs in ANCA-Associated Vasculitis Patients: A Real-World Analysis in Italy in Advances in Therapy

2023
ASL Vercelli

Degli Esposti L; Dovizio M; Perrone V; Veronesi C; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo M; Citraro R; Costantini A; Dell’Orco S; Ferrante F; Gentile S; Grego S; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Ramirez de Arellano A; Gigliotti G; et alii...

Analysis of outcomes and healthcare resource consumption in patients with ANCA-associated vasculitis in a setting of clinical practice in Italy. in Giornale Italiano di Farmacia Clinica

2023
ASL Vercelli

Dovizio M; Perrone V; Veronesi C; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Dell’Orco S; Ferrante F; Gallo L; Gentile S; Grego S; Lavalle A; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Procacci C; Re D; Ubertazzo L; Vercellone A; Gigliotti G; Quartuccio L; Espositi LD;

Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population in Nutrients

2023
ASL Vercelli

Barbuto S; Perrone V; Veronesi C; Dovizio M; Zappulo F; Vetrano D; Giannini S; Fusaro M; Ancona DD; Barbieri A; Ferrante F; Lena F; Palcic S; Re D; Rizzi FV; Cogliati P; Soro M; Esposti LD; Cianciolo G;

HSD64 Drug Discontinuation and Healthcare Cost Evaluation in Crohn's Disease Patients Under Biologic Therapy: An Italian Retrospective Analysis in Value in Health

2022
ASL Vercelli

Perrone V; Secchi O; Serra A; Franchi A; Dovizio M; Sangiorgi D; Andretta M; Antonacci S; Barbieri A; Bartolini F; Cavaliere A; Ciaccia A; Cillo MR; Citraro R; Costantini A; Dell'Orco S; Grego S; Moscogiuri R; Mosele E; Procacci C; Santoleri F; Vercellone A; Degli Esposti L;

Clinical Profile and Healthcare Resource Use of ANCA-Associated Vasculitis: A Real-World Analysis in Italy in Value in Health

2022
ASL Vercelli

Perrone V; Dovizio M; Veronesi C; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Ramirez de Arellano Serna A; Degli Esposti L; et alii...

HSD61 Trends in Discontinuation of Lipid-Lowering and Antihypertensive Therapies: A Real-World Data Analysis in Italy in Value in Health

2022
ASL Vercelli

Dovizio M; Perrone V; Iacolare B; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Maccio S; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Degli Esposti L; et alii...

HSD16 PCSK-9 Inhibitors for the Control of Hypercholesterolemia: Eligibility for Treatment, Prescription Appropriateness and Outcomes, in a Real-World Clinical Setting in Value in Health

2022
ASL Vercelli

Perrone V; Iacolare B; Dovizio M; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Maccio S; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Degli Esposti L; et alii...

POSA310 Artificial Intelligence Applied on Administrative Big Data to Predict the Severity of SARS-COV-2 Infection in Value in Health

2022
ASL Vercelli

Iacolare B; Perrone V; Sangiorgi D; Ghigi A; Giacomini E; Nappi C; Paoli D; Ancona DD; Andretta M; Barbieri A; Bartolini F; Cavaliere A; Ciaccia A; Citraro R; Dell'Orco S; Ferrante F; Gentile S; Grego S; Procacci C; Ubertazzo L; Vercellone A; Degli Esposti L;

P2 Estimation of Metastatic Colorectal Cancer Patients Carrying BRAF Mutation Potentially Eligible to Targeted Therapy: A Real-World Evidence Study in Italy in Value in Health

2022
ASL Vercelli

Degli Esposti L; Sangiorgi D; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; De Francesco A; Enieri N; Ferrante F; Gentile S; Lavalle A; Mancini D; Mensurati M; Moscogiuri R; Pastorello M; Procacci C; Re D; Santoleri F; Serao Creazzola S; Tegon M; Ubertazzo L; Vercellone A; Perrone V; et alii...

POSB240 The Effects of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: The Fail-to-Refill Project in Value in Health

2022
ASL Vercelli

Degli EL; Ghigi A; Ancona DD; Andretta M; Barbieri A; Bartolini F; Cavaliere A; Ciaccia A; Dell'Orco S; Di MG; Grego S; Latini M; Luboz J; Nava E; Paciello A; Pagliaro R; Penna A; Salzano S; Tonello I; Ubertazzo L; Vercellone A; Perrone V;

Use of Real-World Big Data to Assess the Effectiveness on Overall Survival Among Chemotherapy or Immunotherapy in First Line Metastatic Non-Small Cell Lung Carcinoma Patients in an Italian Setting in Value in Health

2022
ASL Vercelli

Degli Esposti L; Sangiorgi D; Ancona DD; Andretta M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; De Francesco A; Dell'Orco S; Di Manno G; Ferrante F; Gentile S; Lavalle A; Moscogiuri R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Perrone V;

P1 Data-Linkage Between Administrative and Pathological Anatomy Databases for the Identification of Lung Cancer Patients Eligible to Innovative Therapies in Value in Health

2022
ASL Vercelli

Degli Esposti L; Sangiorgi D; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; De Francesco A; Ferrante F; Gentile S; Lavalle A; Mancini D; Mensurati M; Moscogiuri R; Pastorello M; Procacci C; Re D; Santoleri F; Serao Creazzola S; Ubertazzo L; Vercellone A; Perrone V;

POSC156 Clinical Burden, Treatment Pathway, and Healthcare Resource Utilization of Transfusion-Dependent Beta-Thalassemia Patients in Italy: A Retrospective Analysis in Value in Health

2022
ASL Vercelli

Perrone V; Veronesi C; Giacomini E; Ancona DD; Andretta M; Barbieri A; Bartolini F; Bianco D; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Dell'Orco S; Ferrante F; Gentile S; Serao Creazzola S; Pastorello M; Procacci C; Re D; Tegon M; Ubertazzo L; Vercellone A; Degli Esposti L;

POSB249 Retrospective Analysis of Real-World Clinical Outcomes and Healthcare Resource Consumption in Patients with Chronic Kidney Disease With and Without Secondary Hyperparathyroidism in Italy in Value in Health

2022
ASL Vercelli

Perrone V; Veronesi C; Dovizio M; Blini V; Ancona DD; Barbieri A; Ferrante F; Lena F; Maddalena A; Manzoni F; Ognibene A; Palcic S; Re D; Rizzi FV; Viti G; Soro M; Degli Esposti L;

Cardiovascular Events and Mortality in Type-2 Diabetic Patients under Second-Line Treatment with Hypoglycemic Agents: An Italian Real-World Study in Value in Health

2022
ASL Vercelli

Degli EL; Sangiorgi D; Nappi C; Andretta M; Barbieri A; Citraro R; Bartolini F; Cavaliere A; Ciaccia A; Chinellato A; Cillo MR; Dell'Orco S; Ferrante F; Gentile S; Procacci C; Re D; Ubertazzo L; Vercellone A; Perrone V;